4
Changes in Ownership
ENDRA Life Sciences Inc. Filed Acc 0001209191-19-060093
Options or other derivatives
- Chief Financial Officer acquired 148,434.74 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Wells David R. · Chief Financial Officer
Table II: Derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-12-11 | Grant or award : show line 1 in the form Stock option (right to buy) | +138,375 | 138,375 | D | ||
| 2019-12-11 | Grant or award : show line 2 in the form Series A Convertible Preferred Stock | +8.74 | $1,143.68 | $10,000 | 8.74 | D |
| 2019-12-11 | Grant or award : show line 3 in the form Warrants | +10,051 | 10,051 | D |
Loading xslF345X03/doc4.xml…